topotecan has been researched along with dihydropyridines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AY; Liu, LF; Potmesil, M; Wall, ME; Wani, MC; Yu, C | 1 |
| Harstrick, A; Hilger, RA; Klaassen, U; Lindtner, B; Müller, MR; Rustum, YM; Schleucher, N; Seeber, S; Vanhoefer, U | 1 |
| Coburn, RA; Morris, ME; Wang, Q; Yang, X; Zhou, XF | 1 |
3 other study(ies) available for topotecan and dihydropyridines
| Article | Year |
|---|---|
Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells.
Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Camptothecin; Dihydropyridines; Drug Resistance; Humans; KB Cells; Membrane Glycoproteins; Topotecan | 1991 |
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Dihydropyridines; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Neoplasms; Phenotype; Topotecan; Tumor Cells, Cultured | 1999 |
Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Survival; Dihydropyridines; Drug Interactions; Drug Resistance, Multiple; Female; Humans; Inhibitory Concentration 50; Mitoxantrone; Neoplasm Proteins; Pyridines; Rats; Rats, Sprague-Dawley; Topotecan | 2005 |